Sectra ABMIL:1SECT 76 Return-on-Tangible-Equity is 36.85% as of Apr. 2026, which is 6% below its 10-year median of 39.05. GuruFocus rates MIL:1SECT with a GF Score™ of 76/100 and a GF Value™ of €28.93 (Fairly Valued). Among 760 Medical Devices & Instruments companies, Sectra AB ranks better than 89.47% on this metric.
Return-on-Tangible-Equity is calculated as Net Income divided by its average total shareholder tangible equity. Total shareholder tangible equity equals to Total Stockholders Equity minus Intangible Assets. Sectra AB's annualized net income for the quarter that ended in Apr. 2026 was €58.1 Mil. Sectra AB's average shareholder tangible equity for the quarter that ended in Apr. 2026 was €157.7 Mil. Therefore, Sectra AB's annualized Return-on-Tangible-Equity for the quarter that ended in Apr. 2026 was 36.85%.
The historical rank and industry rank for Sectra AB's Return-on-Tangible-Equity or its related term are showing as below:
MIL:1SECT'
s Return-on-Tangible-Equity Range Over the Past 10 Years
Min: 32.97 Med: 39.05 Max: 41.98
Current: 34.12
During the past 13 years, Sectra AB's highest Return-on-Tangible-Equity was 41.98%. The lowest was 32.97%. And the median was 39.05%.
MIL:1SECT's Return-on-Tangible-Equity is ranked better than 89.47% of 760
companies
in the Medical Devices & Instruments industry
Industry Median: 4.115
vs MIL:1SECT: 34.12
Sectra AB (MIL:1SECT) Return-on-Tangible-Equity Explanation
Return-on-Tangible-Equity measures the rate of return on the ownership interest (shareholder's tangible equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' tangible equity (shareholders equity minus intangibles). Return-on-Tangible-Equity shows how well a company uses investment funds to generate earnings growth. Return-on-Tangible-Equitys between 15% and 20% are considered desirable.
Be Aware
Net Income is used.
Because a company can increase its Return-on-Tangible-Equity by having more financial leverage, it is important to watch the leverage ratio when investing in high Return-on-Tangible-Equity companies. Like Return-on-Tangible-Asset, Return-on-Tangible-Equity is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.
Asset light businesses require very few assets to generate very high earnings. Their Return-on-Tangible-Equitys can be extremely high.
Sectra AB Return-on-Tangible-Equity Related Terms
Sectra AB Return-on-Tangible-Equity Historical Data
* Premium members only.
The historical data trend for Sectra AB's Return-on-Tangible-Equity can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
MIL:1SECT vs ABT, SYK, MDT: Return-on-Tangible-Equity Comparison
For the Medical Devices subindustry, Sectra AB's Return-on-Tangible-Equity, along with its competitors' market caps and Return-on-Tangible-Equity data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Sectra AB Return-on-Tangible-Equity vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Sectra AB's Return-on-Tangible-Equity distribution charts can be found below:
* The bar in red indicates where Sectra AB's Return-on-Tangible-Equity falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Return-on-Tangible-Equity, the net income of the last fiscal year and the average total shareholder tangible equity over the fiscal year are used. In calculating the quarterly data,
the net income data used here is four times the quarterly (Apr. 2026) net income data.
Return-on-Tangible-Equity is displayed in the 10-year financial page.
What does a Return-on-Tangible-Equity of 36.85% mean?
Sectra AB (MIL:1SECT) has a Return-on-Tangible-Equity of 36.85% as of Apr. 2026. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on Sectra AB and its competitors. This is near median its historical median of 39.05. Over the past decade, Sectra AB's Return-on-Tangible-Equity has ranged from 32.97 to 41.98. According to the industry distribution chart, Sectra AB ranks #80 out of 760 companies in the Medical Devices & Instruments industry, placing it in the top 10.5%.
Is Sectra AB's Return-on-Tangible-Equity too high?
Sectra AB's current Return-on-Tangible-Equity of 36.85% is near median its 10-year median of 39.05. Over the past 10 years, this metric has ranged from a low of 32.97 to a high of 41.98. The Medical Devices & Instruments industry median Return-on-Tangible-Equity is 4.12. Sectra AB's value of 36.85% is 795.5% above this industry median. Based on the distribution chart, Sectra AB ranks #80 out of 760 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Sectra AB has a GF Score™ of 76/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Sectra AB's Return-on-Tangible-Equity compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Sectra AB ranks #80 out of 760 companies for Return-on-Tangible-Equity. This places Sectra AB in the top 11% of its industry — outperforming the majority of peers. The industry median Return-on-Tangible-Equity is 4.12. Sectra AB's value of 36.85% is 795.5% above this benchmark. Historically, Sectra AB's own Return-on-Tangible-Equity has ranged from 32.97 to 41.98 over the past decade. While the company's 10-year median is 39.05 vs. the industry median of 4.12, Sectra AB has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Return-on-Tangible-Equity for a Medical Devices & Instruments company?
The median Return-on-Tangible-Equity among Medical Devices & Instruments companies is 4.12, based on 760 companies in the industry. Companies in the top quartile (top 25%) have a Return-on-Tangible-Equity significantly above this median, while those in the bottom quartile fall well below. However, Return-on-Tangible-Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Sectra AB's current Return-on-Tangible-Equity of 36.85% is 795.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Return-on-Tangible-Equity mean?
A high Return-on-Tangible-Equity can signal that a stock is expensive relative to its fundamentals. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on Sectra AB and its competitors. For the Medical Devices & Instruments industry, the median Return-on-Tangible-Equity is 4.12 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Sectra AB's current Return-on-Tangible-Equity is 36.85%, which is near median its own 10-year median of 39.05. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sectra AB stock overvalued right now?
Based on GuruFocus' analysis, Sectra AB (MIL:1SECT) is currently considered Fairly Valued. The stock's GF Value™ is €28.93, compared to a current price of €27.38 — trading 5.4% below its estimated fair value. The current Return-on-Tangible-Equity is 36.85%, which is near median its 10-year median of 39.05 and 795.5% above the Medical Devices & Instruments industry median of 4.12. Sectra AB's overall GF Score™ is 76/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Return-on-Tangible-Equity calculated?
Return-on-Tangible-Equity is calculated from a company's financial statements. For Sectra AB (MIL:1SECT), the current Return-on-Tangible-Equity is 36.85% as of Apr. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Sectra AB (MIL:1SECT) Overvalued in 2026?
Based on GuruFocus' analysis, Sectra AB stock appears to be undervalued.
The current stock price of €27.38 is trading 5.4% below its estimated GF Value™ of €28.93.
GuruFocus considers Sectra AB to be Fairly Valued.
Key valuation signals for MIL:1SECT:
Return-on-Tangible-Equity: 36.85% (near median its 10-year median of 39.05)
GF Value™: €28.93 vs. price of €27.38 (5.4% below fair value)
Industry Position: 795.5% above the Medical Devices & Instruments median (#80 of 760)
No single metric tells the full story. See the MIL:1SECT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Sectra AB develops IT solutions and services for storing, viewing, and working with medical images. The operating business segments are Imaging IT Solutions, Secure Communications, Business Innovation, and Other Operations. It generates maximum revenue from the Imaging IT Solutions segment. The company also offers maintenance in the form of support, system monitoring, and consulting services related to integration, system design, data migration, and business development. Geographically, it derives a majority of its revenue from the United States, followed by Sweden, the United Kingdom, the Netherlands, the Rest of Europe, and the Rest of the world.
76GF Score
Get the complete analysis for MIL:1SECT
Return-on-Tangible-Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MIL:1SECT has been successfully added to your 
